drugset / Trial / NCT05018091

Dexamethasone in Total Knee Arthroplasty

NCT05018091 ↗

Phase 4 Completed 404 enrolled Rush University Medical Center
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine the most efficacious and safest dexamethasone dose given intraoperatively during total knee arthroplasty that reduces postoperative opioid consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications.

Timeline

Start
2021-10-28
Primary completion
2025-01-01
Completion
2025-05-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Intravenous
Comparator Dexamethasone Small molecule 8 mg Intravenous
Comparator Dexamethasone Small molecule 16 mg Intravenous

Indications

No indication recorded.